Osteoporosis Treatment at OpenMed Warsaw and Płock

Osteoporosis is a chronic metabolic bone disease characterised by decreased bone mineral density and disruption of bone tissue microarchitecture. In practice, this means weakened bone strength and increased susceptibility to fractures. The disease develops gradually and may produce no symptoms for a long time. Often the first sign is a so-called low-energy fracture, i.e. a fracture resulting from a minor force such as a fall from standing height.

From a medical perspective, osteoporosis results from an imbalance between bone formation and resorption (i.e. bone "breakdown"). In healthy individuals, both processes remain in balance. In osteoporosis, bone mass loss predominates. If you want to check the condition of your bones or start osteoporosis treatment, we invite you to consult our rheumatologists at OpenMed in Warsaw or Płock, where we provide comprehensive diagnostics and an individual therapy plan in one place.

Types of osteoporosis

We distinguish several basic types of the disease:

primary osteoporosis - the most common, related to age and declining oestrogen levels in postmenopausal women; it also includes senile osteoporosis occurring in the elderly,
secondary osteoporosis - developing in the course of other diseases (e.g. hormonal disorders, gastrointestinal diseases, chronic inflammatory conditions) or as a result of long-term use of certain medications, especially glucocorticosteroids,
drug-induced osteoporosis - considered a particular form of secondary osteoporosis, most commonly associated with chronic steroid therapy.

Identifying the type of osteoporosis is important for treatment selection. At OpenMed we always strive to establish the cause of the disease, not merely confirm reduced bone density.

Causes and symptoms of osteoporosis

The main risk factors include: age, menopause, low body weight, calcium and vitamin D deficiency, lack of physical activity, smoking and excessive alcohol consumption. Thyroid and parathyroid diseases, malabsorption disorders and long-term steroid treatment are also significant.

Symptoms are usually non-specific. Bone mass loss itself does not cause pain. Most commonly the first symptom is a vertebral, hip or wrist fracture. In the case of vertebral fractures, sudden back pain, height loss or gradual development of a so-called "osteoporotic hump" may appear.

What does diagnostics look like at OpenMed?

During the consultation, the doctor assesses individual fracture risk based on age, previous injuries, co-existing conditions, medications taken (e.g. glucocorticosteroids) and other factors affecting bone health. If indicated, a densitometric examination (DXA) is ordered, which allows assessment of bone mineral density and forms the basis for treatment decisions. DXA is a short, painless examination that helps determine whether bones require treatment and how intensive therapy should be.

Depending on the situation, our specialists also recommend laboratory tests to exclude secondary causes of osteoporosis and safely plan treatment. If you have had a low-energy fracture (e.g. after a fall from standing height), the priority is rapid implementation of measures that genuinely reduce the risk of further fractures.

What does osteoporosis treatment include? Treatment plan at OpenMed Warsaw and Płock

We tailor the therapy plan individually - differently for someone after a vertebral fracture, differently for a patient on steroids, and differently for prevention before a first fracture. We also discuss your preferences and daily possibilities: whether it is easier to take oral medication, whether an injection or infusion form would be better, what the risk of side effects looks like and what the monitoring rules are. In practice, treatment may include:

pharmacological treatment reducing fracture risk (including bisphosphonates as a frequent first-line choice, and for selected patients other medications, e.g. denosumab or anabolic therapies), with discussion of benefits, side effects and safety principles,
a "monitor and adjust" strategy - we evaluate outcomes and after 3-5 years of bisphosphonate therapy reassess risk, considering continuation or a treatment break for those at lower risk,
nutritional and supplementation support tailored to test results. We discuss appropriate dietary calcium intake and vitamin D supplementation principles, taking into account current blood levels (25(OH)D), because what matters is not just the supplement taken but achieving the proper therapeutic level.
fall prevention and safe movement: weight-bearing and resistance exercises, balance training, and review of medications and factors increasing the risk of stumbling.

It is worth emphasising that supplements alone are not "osteoporosis treatment" - in people at high fracture risk, bone-targeted treatment is key, and supplementation should support therapy when needed and safe as a complement.

Monitoring, safety and long-term care

Osteoporosis requires consistency but does not have to mean living in fear of movement. We establish a clear monitoring plan: when to repeat tests, how to assess treatment effectiveness and what symptoms to watch for (e.g. sudden back pain after a minor injury). We also discuss practical things that make a difference: getting-up technique, safe footwear, home lighting, and building muscle strength and balance, because lower fall risk means fewer fractures.

If you suspect osteoporosis, have had a fracture after a minor injury or want to check your risk before the next decade of life, book a consultation at OpenMed.

Book a medical consultation

We invite you to register for appointments at OpenMed in Warsaw or Płock.

Telephone or online registration - the OpenMed team will help you choose the right date and scope of rheumatology or internal medicine consultation.